6VBG image
Entry Detail
PDB ID:
6VBG
Title:
Lactose permease complex with thiodigalactoside and nanobody 9043
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2019-12-18
Release Date:
2020-11-25
Method Details:
Experimental Method:
Resolution:
2.80 Å
R-Value Free:
0.27
R-Value Work:
0.23
R-Value Observed:
0.24
Space Group:
P 65
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Galactoside permease
Mutations:G46W, G262W
Chain IDs:A, C (auth: B)
Chain Length:417
Number of Molecules:2
Biological Source:Escherichia coli
Polymer Type:polypeptide(L)
Description:nanobody 9043
Chain IDs:B (auth: C), D
Chain Length:121
Number of Molecules:2
Biological Source:Lama glama
Ligand Molecules
Primary Citation
Diversity in kinetics correlated with structure in nano body-stabilized LacY.
Plos One 15 e0232846 e0232846 (2020)
PMID: 32380514 DOI: 10.1371/journal.pone.0232846

Abstact

The structure of lactose permease, stabilized in a periplasmic open conformation by two Gly to Trp replacements (LacYww) and complexed with a nanobody directed against this conformation, provides the highest resolution structure of the symporter. The nanobody binds in a different manner than two other nanobodies made against the same mutant, which also bind to the same general region on the periplasmic side. This region of the protein may represent an immune hotspot. The CDR3 loop of the nanobody is held by hydrogen bonds in a conformation that partially blocks access to the substrate-binding site. As a result, kon and koff for galactoside binding to either LacY or the double mutant complexed with the nanobody are lower than for the other two LacY/nanobody complexes though the Kd values are similar, reflecting the fact that the nanobodies rigidify structures along the pathway. While the wild-type LacY/nanobody complex clearly stabilizes a similar 'extracellular open' conformation in solution, judged by binding kinetics, the complex with wild-type LacY did not yet crystallize, suggesting the nanobody does not bind strongly enough to shift the equilibrium to stabilize a periplasmic side-open conformation suitable for crystallization. However, the similarity of the galactoside binding kinetics for the nanobody-bound complexes with wild type LacY and with LacYWW indicates that they have similar structures, showing that the reported co-structures reliably show nanobody interactions with LacY.

Legend

Protein

Chemical

Disease

Primary Citation of related structures